Page last updated: 2024-08-22

trimetazidine and phosphocreatine

trimetazidine has been researched along with phosphocreatine in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19902 (33.33)18.7374
1990's1 (16.67)18.2507
2000's2 (33.33)29.6817
2010's0 (0.00)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Lavanchy, N; Martin, J; Rossi, A2
Aussedat, J; Harpey, C; Kay, L; Ray, A; Rossi, A; Verdys, M1
Calori, G; De Cobelli, F; Del Maschio, A; Esposito, A; Fragasso, G; Lattuada, G; Margonato, A; Palloshi, A; Perseghin, G; Scifo, P1
Bian, YY; Cao, KJ; Chen, XJ; Feng, L; Li, P; Meng, D; Yang, D; Zhang, JN1
Allaart, CP; Bakermans, AJ; Bronzwaer, PNA; de Man, FS; Geurkink, KTJ; Handoko, ML; Kok, WEM; Nederveen, AJ; Oosterveer, FTP; van de Bovenkamp, AA; van Rossum, AC1

Trials

2 trial(s) available for trimetazidine and phosphocreatine

ArticleYear
Effects of metabolic modulation by trimetazidine on left ventricular function and phosphocreatine/adenosine triphosphate ratio in patients with heart failure.
    European heart journal, 2006, Volume: 27, Issue:8

    Topics: Adenosine Triphosphate; Aged; Cross-Over Studies; Double-Blind Method; Echocardiography; Female; Heart Failure; Hemodynamics; Humans; Magnetic Resonance Angiography; Male; Phosphocreatine; Prospective Studies; Trimetazidine; Vasodilator Agents; Ventricular Dysfunction, Left

2006
Trimetazidine in heart failure with preserved ejection fraction: a randomized controlled cross-over trial.
    ESC heart failure, 2023, Volume: 10, Issue:5

    Topics: Adenosine Triphosphate; Aged; Cross-Over Studies; Female; Heart Failure; Humans; Male; Phosphocreatine; Stroke Volume; Trimetazidine

2023

Other Studies

4 other study(ies) available for trimetazidine and phosphocreatine

ArticleYear
[Trimetazidine preservation of the energy potential of the myocardium during ischemia and reperfusion. Phosphorus NMR spectroscopy study of the isolated heart].
    Presse medicale (Paris, France : 1983), 1986, Oct-16, Volume: 15, Issue:35

    Topics: Adenosine Triphosphate; Animals; Coronary Circulation; Coronary Disease; Female; Hydrogen-Ion Concentration; In Vitro Techniques; Magnetic Resonance Spectroscopy; Phosphocreatine; Phosphorylation; Piperazines; Rats; Rats, Inbred Strains; Trimetazidine

1986
Anti-ischemic effects of trimetazidine: 31P-NMR spectroscopy in the isolated rat heart.
    Archives internationales de pharmacodynamie et de therapie, 1987, Volume: 286, Issue:1

    Topics: Adenosine Triphosphate; Animals; Coronary Disease; Energy Metabolism; Female; Magnetic Resonance Spectroscopy; Myocardium; Phosphates; Phosphocreatine; Phosphorylation; Piperazines; Rats; Rats, Inbred Strains; Trimetazidine

1987
Improvement of long-term preservation of isolated arrested rat heart: beneficial effect of the antiischemic agent trimetazidine.
    Journal of cardiovascular pharmacology, 1993, Volume: 21, Issue:1

    Topics: Adenosine Triphosphate; Animals; Cardioplegic Solutions; Coronary Circulation; Female; Glycogen; Heart; Hydrogen-Ion Concentration; Lactates; Lactic Acid; Magnetic Resonance Spectroscopy; Myocardium; Organ Preservation; Phosphocreatine; Rats; Rats, Wistar; Trimetazidine; Ventricular Function, Left

1993
Protective effect of astragalosides on myocardial injury by isoproterenol in SD rats.
    The American journal of Chinese medicine, 2006, Volume: 34, Issue:6

    Topics: Adenosine Triphosphate; Animals; Astragalus propinquus; Calcium; Cardiotonic Agents; Drugs, Chinese Herbal; Heart Injuries; Injections, Subcutaneous; Isoproterenol; Male; Myocardium; Myocytes, Cardiac; Phosphocreatine; Random Allocation; Rats; Rats, Sprague-Dawley; Trimetazidine; Vasodilator Agents

2006